This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ypsomed Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Manuel Hulliger: Innovator in Medicament Delivery Technology
Introduction
Manuel Hulliger is a notable inventor based in Gerlafingen, Switzerland. He has made significant contributions to the field of medicament delivery devices, showcasing his innovative spirit through his patented technology.
Latest Patents
Hulliger holds a patent for an "Electronic module for medicament delivery device." This electronic module is designed for releasable attachment to a medicament delivery device. It includes a printed circuit board with an electronic circuit, a battery, and a switch for activating the electronic module. The switch features an electric activation contact that connects with the electronic circuit and a battery contact extension that extends from a terminal of the battery. The design allows for the battery contact extension to engage an actuation element of the medicament delivery device, creating a reliable mechanism for medicament delivery.
Career Highlights
Manuel Hulliger is associated with Ypsomed AG, a company known for its innovative solutions in the field of medical technology. His work at Ypsomed AG has allowed him to focus on developing advanced medicament delivery systems that enhance patient care.
Collaborations
Some of his coworkers include Stefan Mangold and Leoni Etter, who contribute to the collaborative environment at Ypsomed AG. Their combined expertise fosters innovation and drives the development of cutting-edge medical technologies.
Conclusion
Manuel Hulliger's contributions to the field of medicament delivery devices exemplify his commitment to innovation and improving healthcare solutions. His patent reflects a significant advancement in technology that benefits both healthcare providers and patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
